Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...